ArticleBritish journal of clinical pharmacology2026
A survey of community pharmacists perspectives on monitoring antidepressant adverse events.
Article in British journal of clinical pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A survey of community pharmacists perspectives on monitoring antidepressant adverse events.British journal of clinical pharmacology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study assessed pharmacists' experiences and perspectives on monitoring antidepressant adverse events. A stratified sample of 1000 community pharmacists in Dutch-speaking Belgium was invited to complete an online survey on general views on adverse event monitoring and antidepressant adverse event monitoring practice at first and second dispensing and after 1 year. Descriptive statistics were used for analysis. The response rate was 24.4% (244/1000). Overall, pharmacists generally reported positive attitudes towards monitoring antidepressant adverse events, although less positive than for other medicines. Although pharmacists felt well-positioned and trained to monitor adverse events, their approach remains largely passive. Most pharmacist informed patients at first dispensing, but only 47% proactively inquired at second dispensing and 9% at dispensing after 1 year. Only 19% felt comfortable discussing sexual dysfunction. In conclusion, despite community pharmacists' positive perspectives, proactive monitoring declined over time highlighting the need for patient, healthcare provider and policy level interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.